CLBS insider trading
CALADRIUS BIOSCIENCES, INC.: insider trade history from SEC Form 4 filings.
CLBS insider activity at a glance
FilingIQ tracks 188 insider transactions for CLBS in filings since Jun 18, 2015. The most recent transaction is dated Sep 1, 2022.
Across the full history, 5 open-market purchases
and 14 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest CLBS Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Frequently asked
- How many insider trades does FilingIQ track for CLBS?
- FilingIQ tracks 188 Form 4 insider transactions for CLBS (CALADRIUS BIOSCIENCES, INC.), covering filings from Jun 18, 2015 onwards. 0 of those are dated within the last 90 days.
- Are CLBS insiders net buyers or net sellers?
- Across the full Form 4 history for CLBS, 5 transactions (3%) were open-market purchases and 14 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CLBS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
Methodology & sources
Every CLBS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.